Offering you a complete choice of products which include actilyse 50mg injection, actilyse 20 mg injection and crenzlo injection 1.5ml.
₹ 49921 / Piece Get Latest Price
| Drug Strength | 50 mg |
| Packaging Size | 50 mg per vial |
| Composition | Alteplase |
| Strength | 50 mg |
| Manufacture By | BOEHRINGER INGELHEIM INDIA PVT LTD |
| usage | Acute massive pulmonary embolism (blood clots in the lung) |
Minimum order quantity: 1 Piece
Actilyse 50 mg injection contains an active component as Alteplase. It is also known as recombinant tissue plasminogen activator (rt-PA). Actilyse used to treat certain medical conditions involving blood clots. It is a thrombolytic agent, meaning it helps to break down blood clots. This medication is commonly used to manage acute ischemic strokes, where a blood clot blocks blood flow to the brain, leading to potential brain damage.
By administering Actilyse injection within a specific time frame after the onset of stroke symptoms, doctors aim to restore blood flow to the affected brain tissue and reduce the risk of long-term disability. By restoring blood flow to the affected brain area, Actilyse 50mg injection can help minimize the extent of brain tissue damage caused by the stroke.
This can lead to a reduction in long-term disability and an improved chance of recovery for stroke patients. As with any medication, Actilyse 50mg can have side effects, and it may not be suitable for every patient. Common side effects include bleeding, particularly in the brain or gastrointestinal tract. Before administering it, usually, doctors assess the patient's medical history and consider any contraindications
₹ 23906 / Piece Get Latest Price
| Drug Strength | 20 mg |
| Packaging Size | box |
| Composition | alteplase |
| Strength | 20 mg |
| Manufacture By | BOEHRINGER INGELHEIM INDIA PVT LTD |
| usage | Acute massive pulmonary embolism (blood clots in the lung) |
Actilyse 20mg injection contains an active component as Alteplase. It is also known as recombinant tissue plasminogen activator (rt-PA), used to treat certain medical conditions involving blood clots. It is a thrombolytic agent, meaning it helps to break down blood clots. This medication is commonly used to manage acute ischemic strokes, where a blood clot blocks blood flow to the brain, leading to potential brain damage. By administering atelpase within a specific time frame after the onset of stroke symptoms, doctors aim to restore blood flow to the affected brain tissue and reduce the risk of long-term disability. By restoring blood flow to the affected brain area, Actilyse 20mg injection can help minimize the extent of brain tissue damage caused by the stroke. This can lead to a reduction in long-term disability and an improved chance of recovery for stroke patients. As with any medication, this medication can have side effects, and it may not be suitable for every patient. Common side effects include bleeding, particularly in the brain or gastrointestinal tract. Before administering it, usually, doctors assess the patient's medical history and consider any contraindications.
Patients who have a known allergy or hypersensitivity to Actilyse 20mg injection or any of its components should not receive this medication. Patients with significant trauma (head trauma or internal injuries) within the past three months due to an increased risk of bleeding should avoid this medication. This medication is cleared from the body through the liver and kidneys, so caution is advised in patients with severe liver or kidney impairment. Advanced age can increase the risk of bleeding complications with this medication, particularly in patients over 75.
₹ 96000 / Piece Get Latest Price
| Country of Origin | Made in India |
| composition | Inclisiran |
| strenghth | 1.5 ml |
| company | Mankind pharma |
| usage | Combination to other statin therapy and diet for treating primary hyperlipidemia [heterozygous famil |
Minimum order quantity: 1 Piece
Crenzlo Injection 1.5ml is a medicine containing Inclisiran as an active ingredient which belongs to the class of medications called proprotein convertase subtilisin kexin type-9 [PCSK-9]. It is first in class and only small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol. It is used to lower the level of low density lipoprotein. It is prescribed as a complement to statin medication and diet in the management of patients with primary high cholesterol levels.
It is not recommended to use this medication if you are allergic to the active compound Crenzlo Injection 1.5ml or its components. It is not recommended to use during pregnancy and breastfeeding; it is advised to consult your physician regarding further queries. It is not recommended for children and adolescents under the age of 18. You should be taking a statin and following a diet to reduce your cholesterol before beginning this therapy. For the duration that you are receiving Crenzlo Injection 1.5ml, you should continue taking the statin and adhering to this cholesterol-lowering diet. Do not stop taking this medicine without consulting your doctor. Talk to your doctor if you have kidney disorders, breathing problems, liver disorders, heart problems, or intolerance to sugars before taking this medicine. Inform your physician or pharmacist of any additional medications you are taking, have recently taken, or may take, including over-the-counter medications and herbal remedies. Crenzlo Injection price varies on retailer and location.
Mr. Pravinbhai Thakkar (Proprietor)
S.S.Healthcare
34, 34 Swastik Chamber, Incometax ,Ashram Road, Ahmedabad - 380014, Gujarat, India